If Congress starts reviewing licensing deals, diligence gets a documentation problem
Kivo reports that the Biotech Investment National Security Act of 2026 will expand U.S. licensing deal reviews to include biotechnology, creating new documentation requirements.
← Back to stories
National13 articles from 9 sources across the spectrum· Updated 2d ago
1 across the spectrum · tap a section to jump
Left
0 viewpointsSame wire story as other lanes. No original Left take here.
If Congress starts reviewing licensing deals, diligence gets a documentation problem
Center
1 viewpointRan by 11 outlets· KRDO, KVIA El Paso, +9 more
Right
0 viewpointsSame wire story as other lanes. No original Right take here.
If Congress starts reviewing licensing deals, diligence gets a documentation problem